Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05714995 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Therapeutic Approach of Aromatherapy by Olfaction of Essential Oils in Association With Hypnosis in the Management of Patients Followed for Cancer

Study acronym: HYPNO-AROMA
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 11, 2026 (before its estimated October 10, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates: Apr 10, 2026 to Oct 10, 2026v10
  2. Minor Primary and study completion dates: Apr 2026 to Apr 10, 2026v9
  3. Minor Eligibility criteria expanded, about 16 words
    • Study description expanded, about 16 words
    v8
  4. Notable Primary and study completion dates: Oct 2024 to Apr 2026v7
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2024 to Apr 10, 2024
    • Site details revised
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Start date: Nov 2023 to Apr 2024
    • Primary and study completion dates: May 2024 to Oct 2024
    v5
  2. Notable Start date: Sep 2023 to Nov 2023
    • Primary and study completion dates: Mar 2024 to May 2024
    v4
  3. Notable Start date: May 2023 to Sep 2023
    • Primary and study completion dates: Nov 2023 to Mar 2024
    v3
  4. Notable Start date: Feb 2023 to May 2023
    • Primary and study completion dates: Aug 2023 to Nov 2023
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients having the following gestures (blood test, change of dressing for cancerous lesion and complete toilet in bed) will be identified by the team of the medical oncology department. During the first contact (V0), the study will be presented to the patients in order to obtain their consent. Anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.1). The gesture will then be performed and the patient's comfort will be evaluated after the gesture is performed in order to obtain the starting data for the study. Patients will be reviewed in consultation according to the time recommended for each type of gesture. During the second contact V1 (between 1 and 9 days after D0) anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.2). Patients will then be randomized. After randomization, the first hypnosis session will be performed at the same time as gesture No. 2 and the patient's comfort will be evaluated after the gesture is performed. The patient will receive the self-hypnosis training on the same day. A period of 7 ± 2 days will be considered for the learning time of self-hypnosis. The third contact will take place on day D7+/-2 after V1. During this visit, anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.3). Gesture No.3 will be carried out under the effect of self-hypnosis ± aromatherapy and the measurement of comfort will be carried out immediately afterwards
Trial Details
NCT Number NCT05714995
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Conditions
(from sponsor)
Cancer
Related terms Neoplasms
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov